From: Factors of interrupting chemotherapy in patients with Advanced Non-Small-Cell Lung Cancer
Patients Characteristics | Number (Percent) |
---|---|
Total | 45 (100) |
Age, years | |
Median | 58.5 |
Range | 34.7 - 76.9 |
Gender | |
Male | 30 (66.7) |
Female | 15 (33.3) |
ECOG Performance Status | |
Assessed by the physician | |
0 | 4 (9.3) |
1 | 23 (53.5) |
>1 | 16 (37.2) |
Self-assessed by the patient | |
0 | 0 (0.0) |
1 | 17 (37.8) |
>1 | 28 (62.2) |
Weight loss > 10% | 6 (14.0) |
Number of metastases | |
1 | 8 (18.2) |
2 | 21 (47.7) |
>2 | 15 (34.1) |
Site of metastases | |
Bone | 11 (24.4) |
Liver | 14 (31.1) |
Lung | 28 (62.2) |
Brain | 12 (26.7) |
Previous treatment | |
Adjuvant chemotherapy | 4 (8.9) |
Treatment completed | |
First-line | 29 (72.5) |
Second-line | 9 (22.5) |
>Second-line | 2 (5.0) |
Treatment after inclusion | |
Palliative chemotherapy | 45 (100.0) |